A prospective study analysing impact of PCV-13 on nasopharyngeal carriage rates of streptococcus pneumoniae in a rural community in the Dominican Republic
Latest Information Update: 08 Sep 2021
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 08 Sep 2021 New trial record
- 01 Sep 2021 Results published in the Journal of Infectious Diseases